Gene Therapy Forum 2026 conference encourages researchers and practitioners to submit original contributions.
// SCIENTIFIC SESSION
Key Topics
AI & Digital Innovation in CGT
Next-Generation Gene Editing
Cell Therapy & Advanced Cell Engineering
In Vivo & Ex Vivo Therapies
Gene Delivery & Vector Technologies
Manufacturing & Scale-Up
Clinical Trials & Translational Medicine
Regulatory & Market Access
Commercialization & Partnerships
Analytics & Biomarkers
Ethics, Safety & Long-Term Monitoring
Analytics, Genomics & Quality Control
Gene Therapy for Major Diseases
Cell & Gene Therapy Integration
Abstract Submission deadline:June 30, 2026
Abstract Submission
Abstract Submission Guidelines
Overview of Abstract Submission and Evaluation Process:
Abstracts submitted to the conference should be written in English only.
Abstracts should be submitted as per the template available above.
Authors can submit their abstracts in Doc, Docx and Pdf format.
Any act of plagiarism is totally unacceptable.
Each abstract should be contains about 500 words, 400 abstract and 100 biography.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
The type of presentation should be nominated while submitting the abstract.
The abstract submission should be made via conference website only.
Submissions not meeting these guidelines risk rejection without consideration of their merits.
Notification of acceptance or rejection of the scientific committee will be given after a week of submission.
All accepted abstracts will be published in the conference proceedings and the proceedings book will be distributed to all the conference attendees at the registration desk on the day of the conference.